Lista de obras - Alejandro Forner - Dominio Público Uruguay

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2010

Ablation for hepatocellular carcinoma: Is there need to have a winning technique?

artículo científico publicado en 2010

Ablative techniques and the clinical utility of ablation as first-line treatment in the initial phase of hepatocellular cancer

artículo científico publicado en 2014

Adherence and quality are key for a beneficial HCC surveillance

artículo científico publicado en 2020

Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.

artículo científico publicado en 2009

Are alpha-fetoprotein and other markers useful in the diagnosis and prognosis of hepatocellular carcinoma?

artículo científico publicado en 2013

Biomarkers for early diagnosis of hepatocellular carcinoma

artículo científico publicado en 2012

Carbon-ion radiotherapy for HCC-A potential tool to fulfil an unmet gap in the treatment algorithms?

scientific article published on 01 December 2018

Chemoembolization for intermediate HCC: Is there proof of survival benefit? ⬇️

artículo científico publicado el 17 de octubre de 2011

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics

artículo científico publicado en 2006

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

artículo científico publicado en 2020

Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.

artículo científico publicado en 2009

Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques

artículo científico

Clinical presentation, diagnosis and staging of cholangiocarcinoma

artículo científico publicado en 2019

Clinical research in hepatocellular carcinoma: study design and endpoints

artículo científico publicado en 2009

Conclusive HCC diagnosis with hepatocyte-specific contrast-enhanced magnetic resonance imaging? Not yet

artículo científico publicado en 2016

Consensus report of the Fifth International Forum for Liver MRI.

artículo científico publicado en 2013

Current strategy for staging and treatment: the BCLC update and future prospects.

artículo científico publicado en 2010

Diagnosis and staging of hepatocellular carcinoma prior to transplantation: Expertise or failure

artículo científico publicado en 2006

Diagnosis and treatment of hepatocellular carcinoma

artículo científico publicado en 2009

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

artículo científico publicado en 2008

Diagnóstico temprano del cáncer de hígado

scientific article published on 01 May 2005

Does ramucirumab deserve a second chance for liver cancer?

artículo científico publicado en 2015

Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib

artículo científico publicado en 2014

Early diagnosis of primary liver cancer: imaging versus genetics

artículo científico publicado en 2008

East meets the West--portal pressure predicts outcome of surgical resection for hepatocellular carcinoma

artículo científico publicado en 2008

Ecografía con contraste en el diagnóstico del carcinoma hepatocelular

scientific article published on 08 December 2012

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

artículo científico publicado en 2009

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

artículo científico publicado en 2010

Hepatocellular carcinoma

artículo científico publicado en 2018

Hepatocellular carcinoma surveillance with miRNAs

artículo científico publicado en 2015

Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery

artículo científico publicado en 2014

Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

artículo científico publicado en 2015

Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study

artículo científico publicado en 2017

IFN-free therapy for HIV/HCV-coinfected patients within the liver transplant setting

artículo científico publicado en 2016

Ileal carcinoid tumor as a cause of massive lower-GI bleeding: the role of capsule endoscopy

artículo científico publicado en 2004

Increasing alternatives in systemic treatment for hepatocellular carcinoma: Will algorithms be understandable?

artículo científico publicado en 2020

Intermediate-stage HCC—upfront resection can be feasible

artículo científico publicado en 2015

Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound

scientific article published on 01 June 2010

Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.

artículo científico publicado en 2014

Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.

artículo científico publicado en 2015

Liver metastases of intrahepatic cholangiocarcinoma: implications for a potential new staging system

artículo científico publicado en 2020

Locoregional treatment for hepatocellular carcinoma: From clinical exploration to robust clinical data, changing standards of care

Management of HCC

artículo científico publicado en 2012

Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma

artículo científico publicado en 2010

New aspects of diagnosis and therapy of hepatocellular carcinoma.

artículo científico publicado en 2006

New challenges in clinical research on hepatocellular carcinoma.

artículo científico publicado en 2015

New drugs for the treatment of hepatocellular carcinoma.

artículo científico publicado en 2009

Non-invasive diagnosis of hepatocellular carcinoma ⩽2cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI

artículo científico publicado en 2012

Non-invasive diagnostic criteria for hepatocellular carcinoma: the value of contrast washout at imaging and the death of alpha-fetoprotein

artículo científico publicado en 2011

Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials

artículo científico publicado en 2020

Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design

artículo científico publicado en 2013

Prognosis assessment by pathologist: Is the detection of intratumoural tertiary lymphoid structures a reliable tool?

artículo científico publicado en 2018

Prognosis prediction and staging

artículo científico

Prognostic prediction in patients with hepatocellular carcinoma.

artículo científico publicado en 2005

Prospective evaluation of gadoxetic acid magnetic resonance for the diagnosis of hepatocellular carcinoma in newly detected nodules ≤2 cm in cirrhosis

scientific article published on 28 May 2019

Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.

artículo científico publicado en 2015

Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma

artículo científico publicado en 2012

Recommendations for the management of Sorafenib in patients with hepatocellular carcinoma

artículo científico publicado en 2010

Reply to: ''Poor contrast enhanced ultrasonography! There is no limit to its decline in the diagnosis of hepatocellular carcinoma on cirrhosis!''.

artículo científico publicado en 2015

Should Artificial Intelligence‐based language models be allowed in developing scientific manuscripts? A debate between <scp>ChatGPT</scp> and the editors of <i>Liver International</i>

artículo científico publicado en 2023

Sorafenib in advanced hepatocellular carcinoma

artículo científico publicado en 2008

Sunitinib and the benefits of a negative study.

artículo científico publicado en 2009

Surveillance for hepatocellular carcinoma

artículo científico publicado en 2016

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

artículo científico publicado en 2012

Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib

artículo científico publicado en 2019

Systemic therapy for hepatocellular carcinoma: the issue of treatment stage migration and registration of progression using the BCLC-refined RECIST.

artículo científico publicado en 2014

The size of the problem: clinical algorithms

artículo científico publicado en 2013

To Expand or Not to Expand the Criteria for Hepatocellular Carcinoma Transplantation: Is Downstaging the Answer?

artículo científico publicado en 2009

Transarterial chemoembolization for patients with hepatocellular carcinoma

artículo científico publicado en 2007

Transarterial therapies in HCC: does embolization increase survival?

artículo científico publicado en 2009

Treatment of advanced hepatocellular carcinoma

artículo científico publicado en 2010

Treatment of early hepatocellular carcinoma: Towards personalized therapy

artículo científico publicado en 2010

Treatment of hepatocellular carcinoma

artículo científico publicado en 2006

Treatment of intermediate-stage hepatocellular carcinoma

artículo científico

What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?

scientific article published on October 2011

[Hepatocellular carcinoma: diagnosis, staging, and treatment strategy]

artículo científico publicado en 2010

[Imaging diagnosis of hepatocellular carcinoma. Addendum to hepatocellular carcinoma: diagnosis, staging and treatment strategies]

artículo científico publicado en 2011

[Imaging techniques in hepatocellular carcinoma: diagnosis, extension and evaluation of therapeutic response].

artículo científico publicado en 2010

[Massive pulmonary embolism after endoscopic sclerosis with N-butyl-2-cyanoacrylate]

artículo científico publicado en 2006

Lista de obras de Alejandro Forner

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

Ablation for hepatocellular carcinoma: Is there need to have a winning technique?

Ablative techniques and the clinical utility of ablation as first-line treatment in the initial phase of hepatocellular cancer

Adherence and quality are key for a beneficial HCC surveillance

Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.

Are alpha-fetoprotein and other markers useful in the diagnosis and prognosis of hepatocellular carcinoma?

Biomarkers for early diagnosis of hepatocellular carcinoma

Carbon-ion radiotherapy for HCC-A potential tool to fulfil an unmet gap in the treatment algorithms?

Chemoembolization for intermediate HCC: Is there proof of survival benefit? ⬇️

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.

Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques

Clinical presentation, diagnosis and staging of cholangiocarcinoma

Clinical research in hepatocellular carcinoma: study design and endpoints

Conclusive HCC diagnosis with hepatocyte-specific contrast-enhanced magnetic resonance imaging? Not yet

Consensus report of the Fifth International Forum for Liver MRI.

Current strategy for staging and treatment: the BCLC update and future prospects.

Diagnosis and staging of hepatocellular carcinoma prior to transplantation: Expertise or failure

Diagnosis and treatment of hepatocellular carcinoma

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Diagnóstico temprano del cáncer de hígado

Does ramucirumab deserve a second chance for liver cancer?

Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib

Early diagnosis of primary liver cancer: imaging versus genetics

East meets the West--portal pressure predicts outcome of surgical resection for hepatocellular carcinoma

Ecografía con contraste en el diagnóstico del carcinoma hepatocelular

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

Hepatocellular carcinoma

Hepatocellular carcinoma surveillance with miRNAs

Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery

Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study

IFN-free therapy for HIV/HCV-coinfected patients within the liver transplant setting

Ileal carcinoid tumor as a cause of massive lower-GI bleeding: the role of capsule endoscopy

Increasing alternatives in systemic treatment for hepatocellular carcinoma: Will algorithms be understandable?

Intermediate-stage HCC—upfront resection can be feasible

Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound

Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.

Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.

Liver metastases of intrahepatic cholangiocarcinoma: implications for a potential new staging system

Locoregional treatment for hepatocellular carcinoma: From clinical exploration to robust clinical data, changing standards of care

Management of HCC

Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma

New aspects of diagnosis and therapy of hepatocellular carcinoma.

New challenges in clinical research on hepatocellular carcinoma.

New drugs for the treatment of hepatocellular carcinoma.

Non-invasive diagnosis of hepatocellular carcinoma ⩽2cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI

Non-invasive diagnostic criteria for hepatocellular carcinoma: the value of contrast washout at imaging and the death of alpha-fetoprotein

Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials

Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design

Prognosis assessment by pathologist: Is the detection of intratumoural tertiary lymphoid structures a reliable tool?

Prognosis prediction and staging

Prognostic prediction in patients with hepatocellular carcinoma.

Prospective evaluation of gadoxetic acid magnetic resonance for the diagnosis of hepatocellular carcinoma in newly detected nodules ≤2 cm in cirrhosis

Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.

Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma

Recommendations for the management of Sorafenib in patients with hepatocellular carcinoma

Reply to: ''Poor contrast enhanced ultrasonography! There is no limit to its decline in the diagnosis of hepatocellular carcinoma on cirrhosis!''.

Should Artificial Intelligence‐based language models be allowed in developing scientific manuscripts? A debate between <scp>ChatGPT</scp> and the editors of <i>Liver International</i>

Sorafenib in advanced hepatocellular carcinoma

Sunitinib and the benefits of a negative study.

Surveillance for hepatocellular carcinoma

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib

Systemic therapy for hepatocellular carcinoma: the issue of treatment stage migration and registration of progression using the BCLC-refined RECIST.

The size of the problem: clinical algorithms

To Expand or Not to Expand the Criteria for Hepatocellular Carcinoma Transplantation: Is Downstaging the Answer?

Transarterial chemoembolization for patients with hepatocellular carcinoma

Transarterial therapies in HCC: does embolization increase survival?

Treatment of advanced hepatocellular carcinoma

Treatment of early hepatocellular carcinoma: Towards personalized therapy

Treatment of hepatocellular carcinoma

Treatment of intermediate-stage hepatocellular carcinoma

What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?

[Hepatocellular carcinoma: diagnosis, staging, and treatment strategy]

[Imaging diagnosis of hepatocellular carcinoma. Addendum to hepatocellular carcinoma: diagnosis, staging and treatment strategies]

[Imaging techniques in hepatocellular carcinoma: diagnosis, extension and evaluation of therapeutic response].